journal article·2015-08

Microanalysis of Bioactive Samarium Doped Glass-Reinforced Hydroxyapatite

D.S. Morais, J. Coelho, M.A. Lopes, M.P. Ferraz, P. Gomes, M.H. Fernandes, J.D. Santos, N. Sooraj Hussain

Microscopy and Microanalysis· Volume 21· Issue S5
Publisher page

Abstract

In last years, due to the high prevalence of bone defects caused by disorders and injuries, several biomaterials have been developed to be used as bone substitutes [1]. To improve the chemical similarity between these substitutes and bone inorganic part, osteoconductive P2O5 glass-reinforced hydroxyapatite (GR-HA) composites have been developed [2]. The bioactive glasses used in these composites are a source of certain ions, which grants to the composite a bioactive ability, leading to osteointegration [3]. Recently, lanthanide-containing compounds have been studied for several medical applications related with bone tissue [4]. Therefore, in this project, a novel bioactive bone substitute was developed, using a completely new approach based on a samarium (Sm) doped P2O5 glass-reinforced hydroxyapatite (GR-HA). Four composites were prepared, one non-doped (GR-HA_control) and other three doped with different Sm concentrations (GR-HA_0.5Sm, GR-HA_1Sm, GR-HA_2Sm). The composites were physicochemical characterized and the MG63 cells viability on the materials surface was evaluated by SEM and CLSM analysis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Laser-Ablation Synthesis of Nanoparticles · Luminescence Properties of Advanced Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (7)

Show source-provided references
1. 10.1002/(SICI)1097-4636(1999)48:5<734::AID-JBM20>3.0.CO;2-210.1002/(SICI)1097-4636(1999)48:5<734::AID-JBM20>3.0.CO;2-2 ↗
2. 10.1016/j.injury.2005.07.02910.1016/j.injury.2005.07.029 ↗
3. Herath · J. Biomed. Mater. Res. A · 2009 · 94 · 130
4. 10.1016/j.injury.2005.07.02910.1016/j.injury.2005.07.029 ↗
5. The authors would like to acknowledge the financial support from FCT through the project PTDC/SAU-BEB/103034/2008 and from the project ENMED/0002/ 2010.
6. 10.1023/A:101124582804610.1023/A:1011245828046 ↗
7. 10.1016/S0142-9612(00)00007-710.1016/S0142-9612(00)00007-7 ↗